Enzyme inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8686032
APP PUB NO 20130116318A1
SERIAL NO

12957829

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) are inhibitors of histone deacetylase activity, and are useful in the treatment of, for example, cancers:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHROMA THERAPEUTICS LTDABINGDON OXFORDSHIRE OX14 4RY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baker, Kenneth William John Abingdon, GB 5 88
Davidson, Alan Hornsby Abingdon, GB 22 305
Davies, Stephen John Abingdon, GB 32 245
Donald, Alistair David Graham Abingdon, GB 5 136
Drummond, Alan Hastings Abingdon, GB 20 182
Mazzei, Francesca Ann Abingdon, GB 4 124
Moffat, David Festus Abingdon, GB 3 73
Patel, Sanjay Ratilal Abingdon, GB 12 246

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00